Patients with idiopathic inflammatory myopathy (IIM) who are anti-MDA5 antibody positive [anti-MDA5 (+)] often experience chest symptoms during the active disease phase. The gene discussed is IFIH1; the disease is acquired idiopathic inflammatory myopathy.